Abstract
Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 24 patients between March and May 2004 at the Centre Hospitalier de Polynésie Française, Tahiti, French Polynesia. The isolates were multidrug resistant, produced the carbapenemase OXA-23, and belonged to a single clone presenting several subtypes, suggesting an endemic situation. This study further illustrates the global spread of this kind of beta-lactamase-mediated resistance.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acinetobacter Infections / epidemiology*
-
Acinetobacter Infections / microbiology
-
Acinetobacter baumannii / drug effects*
-
Acinetobacter baumannii / enzymology
-
Acinetobacter baumannii / genetics
-
Acinetobacter baumannii / isolation & purification
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Proteins / genetics
-
Bacterial Proteins / metabolism
-
Carbapenems / pharmacology*
-
Child
-
Disease Outbreaks*
-
Female
-
Hospital Bed Capacity, 300 to 499
-
Hospitals*
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Polynesia / epidemiology
-
beta-Lactam Resistance*
-
beta-Lactamases / genetics
-
beta-Lactamases / metabolism*
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Carbapenems
-
beta-lactamase OXA-23
-
beta-Lactamases
-
carbapenemase